According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...
AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...
Perampanel was found effective and safe for prolonged use in children with epilepsy, according to one study. After its 2012 approval as an antiseizure medication, perampanel (Fycompa) has been found ...
Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...
Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...
GOOD LUCK TO YOU TONIGHT. A NEW WAY TO HEAL. THE MOST COMMON CHRONIC BRAIN DISEASE IN THE U.S. EPILEPSY. NEARLY 3 MILLION PEOPLE HAVE IT CAUSING DISRUPTIVE AND DANGEROUS SEIZURES. BUT NOW THERE IS A ...
High up in the hills of Barcelona, brain science start-up Neuroelectrics is developing therapies that it says will improve the lives of people living with brain disease. The group manufactures around ...
1don MSN
AIIMS introduces free drug level testing for epilepsy patients, ends costly outside referrals
In major relief for epilepsy patients, AIIMS New Delhi began providing free Therapeutic Drug Monitoring (TDM) from January 1 ...
Clara was one of the first patients to undergo treatment using NeuroOne’s OneRF ® platform. Since the procedure in June 2024, Clara has been completely seizure-free, which has greatly improved her ...
Shares of Rapport TherapeuticsRAPP catapulted on Monday after the biotech company's experimental drug significantly reduced seizures in patients with a hard-to-treat form of epilepsy. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback